Skip to Content
U.S. National Institutes of Health
Last Updated: 03/05/10

Strategy Group Meeting Agenda

January 8-9, 2001

The Lymphochip: Barriers to Developing a Diagnostic Test Dr. Louis Staudt
Discussion of potential barriers to development of new, comprehensive molecular technologies
Discussion of reports from subcommittees
   Publication guidelines
   Marker development guidelines
   Predictive markers development guidelines
Dr. Lisa McShane
Dr. Liz Hammond
Dr. Joe Gray
Presentations of “promising markers” - application of guidelines
   Microsatellite instability
   Proliferation markers in breast cancer
   Discussion of possible demonstration project
Dr. Barbara Conley
Dr. Sheila Taube
Dr. Soon Paik
Infrastructure issues - tissue micro-arrays and other tissue reference sets; ligand generation facility; device optimization issues